Southampton Clinical Trials Unit to run ground-breaking NHS cancer vaccine programme
Date:
The Southampton Clinical Trials Unit has been chosen to run a new cancer research programme, exploring potentially ground-breaking cancer treatments.
The Cancer Vaccine Launch Pad (CVLP) will improve patient access to clinical trials, allowing researchers to test new investigational immunotherapies by speeding up the development of personalised cancer vaccines.
Thousands of patients across England could benefit from these trials, with University Hospital Southampton one of the first to open to the programme.
To find out more, click here.
